triangulate the data, we integrated insights from the
existing literature.
To ensure validity, we applied a theoretical
replication strategy, using Company B to confirm
findings and explore variations in materials
circularity needs under different operational contexts.
Reliability was maintained through data
triangulation, combining insights from literature,
field visits, and archival documentation. Preliminary
case study analysis contributed to the development of
hypotheses regarding the role of MOM systems in
achieving materials circularity goals.
This approach helped us in presenting the case
study findings in Section 4.
4 ANALYSIS AND FINDINGS
In this section, we present two exemplar case study
narratives of companies on their material circularity
journeys. These international companies have a large
manufacturing footprint and are industry leaders in
their respective sectors, known for their iconic
products.
Case 1 – High end Plastic Consumer Goods: A
global leader in plastic consumer goods
manufacturing, this company boasts an iconic product
and nearly a century of industry presence. With a
widespread manufacturing network spanning five
sites across three continents, it has adaptable supply
chains and an e-commerce platform to cater to the
global demand for personalized products. Company
A offers over 3,000 distinct shapes of components in
a wide range of configurations which are durable for
a long functional lifetime and often passed on into
secondary market. In terms of reuse/recycling this
also means that many generations of material
composition can be found in active market use, some
of which also contain substances that do not live up
to current requirements. This introduces a challenge
in terms of sorting products when they return through
take back programs so that unwanted substances are
not mixed into the material pool.
Company A has for 20 years been actively
engaged in changing the composition of its materials
platform and is under increasing internal and external
pressure to adopt sustainable practices, particularly in
terms of reducing plastic waste and improving
product recyclability.
In the 2010s, Company A integrated a new
comprehensive PLM system into its enterprise
platform to accelerate product launches and enhance
master data management across its supply chain. This
integration has driven increased automation in
product launches, production planning, control, and
lifecycle management, resulting in a notable
improvement in product output through more
granular control over materials, production processes,
and product flows. The upgraded data systems have
provided deeper insights into costs and
manufacturing structures, facilitating more informed
decision-making. A recent initiative focuses on
experimenting with dynamic recipes to align material
composition, process parameters, and advanced
customer requirements. Initially aimed at boosting
process control and optimization, this program, as it
evolves, will enable more significant changes in
material composition, processes, and customization.
These changes, whether process optimizations or new
elements, often require extensive testing and
validation, but digital twins within the industrial
metaverse now serve as a central hub to integrate
operational systems into a unified virtual
environment. For example, recipe adjustments can be
simulated and automatically updated across
connected systems.
Case 2 – Pharmaceuticals and Health Care
(Packaging): Company B is a global leader in the
pharmaceutical industry, known for its commitment
to fighting chronic diseases by advancing innovative
medicines and delivery systems. It is a well-
established company operating a vast network of
manufacturing sites across multiple continents.
Company B is also known for its pioneering work in
medicine delivery systems, where it has a self-
reported plastic footprint of 0.35kg per patient despite
concerted efforts to reduce consumption by, among
other things, introducing reusable delivery systems.
Company B faces the challenge of recycling its
plastic medical devices while adhering to stringent
health and safety regulations, which means that
closed loop solutions are not possible under current
circumstances, complicating efforts to improve
product recyclability and reduce plastic waste.
Compared to Company A, ensuring the right
functional properties of the material is not sufficient
for Company B as the documentation trail also need
to comply with regulatory regimes in the market.
Recycled materials often exhibit inconsistent
properties, such as variability in composition,
contamination risks, and reduced mechanical
integrity, which can compromise product safety and
sterility. Regulatory frameworks, including Food and
Drug Administration (FDA) and EU guidelines,
require traceability and compliance, complicating the
use of recycled plastics. Additionally, the